.png){kind=logo}
_edited_edited.png)
It can happen to you
or your loved one.
At any time.
WHY Does This Happen?
EARLY DETECTION IS RARE
Traditional cancer detection relies on CT or MRI scanners, which are limited.
By the time cancer is detected, millions of cancer cells will have grown and traveled around the body.
INCOMPLETE TREATMENT
Current treatments don’t usually “get it all,” allowing cancer to return.
Plus, they produce damaging side effects.
Our Breakthroughs enable earlier cancer detection, and more effective treatment, without the side effects
Our U.S. Patent Was Just Granted! →​
HoloBeam receives $16 million in Series A funding
Because you can’t wait.
We are a laser-focused team that’s working on bringing life-changing solutions to patients.
We have successfully treated cancer in mice and dogs and are diligently working towards getting our diagnosis and treatment protocols and equipment to market for pets and people. Find out how you can support us in our effort.
Endorsed by Experts
From what you’ve done so far, you have a technology that could deliver as much energy as you wanted to, to a highly specified location, which will be very valuable. Because then we could just go burn out tumors left and right,”
- Dr. Raymond Damadian
The inventor of MRI
“When somebody finds a cancer in your brain, which they can’t operate on… and they’re afraid to put radiation in it… they’ll now be able to focus it right on that point where the cancer is; the rest of your brain will never know that it happened… That, to me, is the big deal… Gene has shown that it will work, that he can actually radiate on a location and kill that location, and everything around that location: no energy at all. …We’re talking about a trillion dollar business here.”
- Dr. Anthony J. Tether
Former Director of DARPA
(the U.S. Defense Advanced Research Projects Agency)
“The technique that now is being developed by Gene to produce hyperthermic responses within the tumor, without affecting normal tissue… negates all of the other problems that have been associated with the present use of hyperthermia…”
- Dr. Myron Arlen
Founder of the Surgical Oncology Division at North Shore University (Northwell Health) Hospital
Previously practicing at Memorial Sloan Kettering Cancer Center.
Founder and Chairman of Neogenix Oncology and Precision Biologics Inc.
